title: Pharmacokinetics of adalimumab in Crohn's disease.
authors.affiliation: Université François-Rabelais de Tours, CNRS, GICC UMR 7292, Tours, France, david.ternant@univ-tours.fr.
authors.forename: David
authors.initials: D
authors.lastname: Ternant
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Karmiris
authors.forename: Severine
authors.initials: S
authors.lastname: Vermeire
authors.forename: Céline
authors.initials: C
authors.lastname: Desvignes
authors.forename: Nicolas
authors.initials: N
authors.lastname: Azzopardi
authors.forename: Theodora
authors.initials: T
authors.lastname: Bejan-Angoulvant
authors.forename: Gert
authors.initials: G
authors.lastname: van Assche
authors.forename: Gilles
authors.initials: G
authors.lastname: Paintaud
mesh_terms: D000068879:Adalimumab / Q000097:blood / Q000378:metabolism* / Q000627:therapeutic use; D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D003424:Crohn Disease / Q000188:drug therapy / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D008954:Models, Biological
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000068879:Adalimumab